Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bioxytran Inc
(OP:
BIXT
)
0.0494
UNCHANGED
Streaming Delayed Price
Updated: 2:23 PM EST, Feb 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bioxytran Inc
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
February 02, 2026
Via
ACCESS Newswire
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
February 02, 2026
From
Bioxytran, Inc
Via
ACN Newswire
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
January 30, 2026
Via
Get News
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
January 30, 2026
Via
Get News
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
January 29, 2026
From
Bioxytran
Via
ACN Newswire
Bioxytran's Medical Breakthrough in Fighting All Viruses
September 19, 2024
Via
ACCESSWIRE
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
January 30, 2026
Via
Press Release Distribution Service
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
January 29, 2026
Via
Press Release Distribution Service
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
↗
June 13, 2025
Via
Stocktwits
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
April 09, 2025
Via
Get News
Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization
December 14, 2022
From
BIOXYTRAN, INC.
Via
GlobeNewswire
Bioxytran Interview at the Emerging Growth Conference
December 12, 2022
From
BIOXYTRAN, INC.
Via
GlobeNewswire
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
December 08, 2022
From
BIOXYTRAN, INC.
Via
GlobeNewswire
Bioxytran, Inc. Announces the Reinitiation of Coverage of Its Stock by Avise Analytics
November 22, 2022
From
BIOXYTRAN, INC.
Via
GlobeNewswire
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
November 16, 2022
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END
Via
FinancialNewsMedia
Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print
November 16, 2022
Complete elimination of viral load in 100% of patients at day 7 vs 6% in placebo (p=.001) Complete elimination of viral load in 88% of patients at day 3 vs 0% in placebo (p=.001) Treated population...
Via
FinancialNewsMedia
Bioxytran Scientific Advisor Releases New Book on Brain Metabolism
October 25, 2022
From
BIOXYTRAN, INC.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
